A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies.
Sharma, Manish R. MD *,1; Joshi, Smita S. MD 1; Karrison, Theodore G. PhD 2; Allen, Kenisha MSN 1; Suh, Grace MD 3; Marsh, Robert MD 4; Kozloff, Mark F. MD 5; Polite, Blase N. MD, MPP 1; Catenacci, Daniel V. T. MD 1; Kindler, Hedy L. MD 1
[Article]
Cancer.
125(10):1629-1636, May 15, 2019.
(Format: HTML, PDF)